Biomedical Proteomics

Biomedical Proteomics at CMRI combines applied proteomics with the development of Liquid chromatography–mass spectrometry (LC–MS) based qualitative and quantitative methods for protein identification and characterisation.

SUBMIT A REQUEST OR QUERY

Mass Spectrometry Systems

LC–MS is an extremely powerful analytical strategy for the identification, quantitation, and characterization of biomolecules (e.g. proteins, peptides, carbohydrates, DNA, drugs) in cells, tissues, biological fluids, and
organisms. Modern LC-MS workflows can identify and measure thousands of proteins/protein groups. This enables the study of protein–protein interaction, post-translational modifications, and protein expression and
provides insights into the physiological processes.

Instruments and Service

Please click here for more details on our instrument and services.

WRH Core Facilities

The WRH Biomedical Proteomics core facility is one of nine core facilities at Westmead. WRH core facilities are available for all WRH researchers, external researchers and industry partners. Click here to find out more about what our other facilities have to offer.

LOCATION

The Biomedical Proteomics Facility is located in Children’s Medical Research Institute.